Skip to main content

Table 2 Toxicity of chemotherapy*

From: Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthracycline treatment: a phase II clinical trial

 

Grade 1,2

Grade 3,4

 

/ 39 pts

/ 189 cycles

/ 39 pts

/ 189 cycles

Febrile neutropenia

  

12 (31%)

12 (22%)

Neutropenia

18 (46%)

28 (15%)

15 (39%)

42 (22%)

Thrombocytopenia

18 (46%)

24 (13%)

6 (15%)

9 (5%)

Nausea/vomiting

27 (69%)

42 (22%)

24 (62%)

42 (22%)

Oral mucositis

4 (10%)

5 (3%)

3 (8%)

3 (2%)

Asthenia

12 (31%)

12 (22%)

15 (39%)

24 (13%)

Peripheral neuropathy

6 (15%)

7 (4%)

6 (15%)

9 (5%)

Hearing impairment

3 (8%)

3 (2%)

  

Renal insufficiency

1 (3%)

1 (1%)

  
  1. * Others: abdominal pain(1), skin rash(1), fatigue(6)